Any vaginal bleeding occurring after twelve consecutive months without a menstrual period. It always requires prompt medical assessment, regardless of the amount.
What counts
Any bleeding at all after twelve consecutive period-free months, including light spotting, a single episode, brown or blood-tinged discharge, and bleeding that occurs only after sex.
The volume of bleeding does not correlate reliably with the underlying cause, so a single spot is assessed in the same way as a heavier bleed.
Time elapsed since menopause does not reduce significance. Bleeding ten years after the final period requires the same assessment.
Common causes
| Cause | What it is | Why it matters |
|---|---|---|
| Atrophy of the vaginal and uterine lining | The most frequent cause. As estrogen falls, the tissue thins and becomes fragile, so it bleeds easily. This forms part of genitourinary syndrome of menopause. | Treatable. |
| Endometrial polyps | Growths in the lining of the uterus. | Usually benign, and removable. |
| Fibroids | Growths in the wall of the uterus. They usually shrink after menopause. | Because they normally shrink, new bleeding linked to them warrants attention rather than being assumed to be an old problem. |
| Hormone therapy and hormonal IUDs | Bleeding is more likely in the first few months of use, or after a change in dose. | Expected in some cases, but still reported to your provider rather than assumed. |
| Endometrial hyperplasia | A thickening of the lining of the uterus. | Can precede cancer, and is treatable when it is identified. |
| Endometrial cancer | A minority of cases, but the reason the rule exists. | Highly treatable when caught early. Postmenopausal bleeding is very often its first and only sign. |
| Cervical causes, and less commonly vaginal or vulvar ones | Identified during assessment. | Part of why a physical examination is a routine element of the workup. |
Most postmenopausal bleeding turns out not to be cancer. The most common cause is thin, fragile tissue, which is treatable. But the only way to know which cause applies to you is to have it assessed, and that’s why the rule is the same regardless of how light the bleeding was.
How it is assessed
Assessment usually involves examination, transvaginal ultrasound to measure the endometrium, and a sample of the endometrial lining.
Guidance updated by the American College of Obstetricians and Gynecologists in April 2026 advises that ultrasound and endometrial sampling are generally performed together as the initial assessment, rather than the sample being reserved for cases where the ultrasound is abnormal. The reason is that endometrial thickness measurement alone does not reliably exclude a problem, particularly in the presence of additional risk factors.
Risk factors that raise concern include higher body weight, diabetes, never having been pregnant, unopposed estrogen use, and use of tamoxifen or similar medication.
Endometrial thickness is interpreted differently depending on whether bleeding is present, which is why the measurement is not meaningful in isolation.
When to seek medical advice
- Any bleeding after twelve consecutive period-free months, however light
- Brown or blood-tinged discharge after menopause
- Bleeding after sex
- Bleeding while using vaginal estrogen, which still requires assessment
- Bleeding accompanied by pelvic pain, bloating or unexplained weight loss
Common misconceptions
| Misconception | Truth |
|---|---|
| Light spotting does not count. | It does. The amount of bleeding does not indicate the cause, so any bleeding is assessed the same way. |
| Bleeding on vaginal estrogen explains itself | It can occur, but it is never an explanation that removes the need for assessment. |
| Bleeding after menopause means cancer. | Most cases have a benign cause. Cancer accounts for a minority, which is precisely why assessment rather than assumption is needed in either direction. |
Frequently asked questions
No. Most cases have a benign cause, most commonly thinning of the vaginal and uterine lining. Cancer accounts for a minority of cases. All postmenopausal bleeding still requires prompt assessment, because the cause cannot be determined without investigation.
Atrophy, meaning thinning and fragility of the tissue lining the vagina and uterus as estrogen falls. Endometrial polyps are another frequent cause. Both are treatable.
Promptly. This is not a symptom to monitor over months. Any bleeding after twelve period-free months warrants an appointment, whatever the amount.
Yes. Light spotting, brown discharge and blood-tinged discharge all count. Volume does not reliably indicate the cause.
Examination, transvaginal ultrasound to measure the uterine lining, and a sample of that lining. Updated ACOG guidance from April 2026 advises performing the ultrasound and the sample together as the initial assessment. The sample is typically an office procedure.
It can, but bleeding should never be attributed to it without assessment. Local vaginal estrogen is a well-supported treatment and is not a reason to skip investigation.
They can. Fibroids usually shrink after menopause, so growth or new bleeding associated with them warrants assessment rather than assumption.
No. Time elapsed does not make bleeding less significant, and the same prompt assessment applies.
Brown discharge usually indicates old blood and is treated as postmenopausal bleeding, assessed the same way. Causes range from tissue thinning to polyps to conditions of the uterine lining.
Bleeding can occur with hormone therapy, particularly in the first months of use or after a dose change. It should be reported so a provider can decide whether it fits the expected pattern or needs investigation.
